Gregory L. Verdine, Director at Wave Life Sciences Ltd. (WVE), sold 32,020 shares at $13.09 ($427K) on 2025-12-08, disclosed to the SEC on 2025-12-10.
Scheduled sale ($427k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.09 | 12,020 | $157K | 36.9% |
| 2 | $13.09 | 12,020 | $157K | 36.9% |
| 3 | $14.05 | 7,980 | $112K | 26.3% |
| Total | $13.33 avg | 32,020 | $427K | 100% |
| Filing → |
| WVE | SELL | 2019-11-22 | $1.7M | — | Filing → |
| WVE | SELL | 2018-11-16 | $996K | — | Filing → |
| WVE | SELL | 2016-06-17 | $868K | — | Filing → |